Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Bouck

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Journal of Virology|March 1, 1985
Characterization of a new simian virus 40 mutant, tsA3900, isolated from deletion mutant tsA1499N I Hutchinson, L S Chang, M M Pater, et al.
The Journal of Cell Biology|July 1, 1993
Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activityS S Tolsma, O V Volpert, D J Good, et al.
Genes & Development|June 8, 2001
In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effectsS Filleur, O V Volpert, A Degeorges, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 16, 2003
Proliferative diabetic retinopathy is associated with a low level of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor. a pilot studyB O Boehm, G Lang, B Feldmann, et al.
Journal of Virology|October 1, 1996
A novel simian virus 40 early-region domain mediates transactivation of the cyclin A promoter by small-t antigen and is required for transformation in small-t antigen-dependent assaysA Porrás, J Bennett, A Howe, et al.
Oncology|June 6, 2000
A pilot trial of suramin in metastatic breast cancer to assess antiangiogenic activity in individual patientsW J Gradishar, G Soff, J Liu, et al.
Biochemical and Biophysical Research Communications|December 5, 1995
Inhibition of angiogenesis by thrombospondin-2O V Volpert, S S Tolsma, S Pellerin, et al.
Diabetologia|April 11, 2003
Low content of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor predicts progression of diabetic retinopathyB O Boehm, G Lang, O Volpert, et al.
Cell|July 10, 1998
Thrombospondin-1 is a major activator of TGF-beta1 in vivoS E Crawford, V Stellmach, J E Murphy-Ullrich, et al.
Journal of Cell Science|January 17, 2002
Pigment epithelium-derived factor (PEDF) in neuroblastoma: a multifunctional mediator of Schwann cell antitumor activityS E Crawford, V Stellmach, M Ranalli, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Journal of Virology|March 1, 1985
Characterization of a new simian virus 40 mutant, tsA3900, isolated from deletion mutant tsA1499N I Hutchinson, L S Chang, M M Pater, et al.
The Journal of Cell Biology|July 1, 1993
Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activityS S Tolsma, O V Volpert, D J Good, et al.
Genes & Development|June 8, 2001
In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effectsS Filleur, O V Volpert, A Degeorges, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 16, 2003
Proliferative diabetic retinopathy is associated with a low level of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor. a pilot studyB O Boehm, G Lang, B Feldmann, et al.
Journal of Virology|October 1, 1996
A novel simian virus 40 early-region domain mediates transactivation of the cyclin A promoter by small-t antigen and is required for transformation in small-t antigen-dependent assaysA Porrás, J Bennett, A Howe, et al.
Oncology|June 6, 2000
A pilot trial of suramin in metastatic breast cancer to assess antiangiogenic activity in individual patientsW J Gradishar, G Soff, J Liu, et al.
Biochemical and Biophysical Research Communications|December 5, 1995
Inhibition of angiogenesis by thrombospondin-2O V Volpert, S S Tolsma, S Pellerin, et al.
Diabetologia|April 11, 2003
Low content of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor predicts progression of diabetic retinopathyB O Boehm, G Lang, O Volpert, et al.
Cell|July 10, 1998
Thrombospondin-1 is a major activator of TGF-beta1 in vivoS E Crawford, V Stellmach, J E Murphy-Ullrich, et al.
Journal of Cell Science|January 17, 2002
Pigment epithelium-derived factor (PEDF) in neuroblastoma: a multifunctional mediator of Schwann cell antitumor activityS E Crawford, V Stellmach, M Ranalli, et al.
Pageof 5